Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR7 | Q9NYK1 | 4/20 | 0.51 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | GPR3 | P46089 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.42 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.41 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.40 |
| ▸ | METAP2 | P50579 | 1/20 | 0.40 |
| ▸ | AKT1 | P31749 | 1/20 | 0.40 |
| ▸ | AKT2 | P31751 | 1/20 | 0.40 |
| ▸ | TOP2A | P11388 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14259886 | 0.86 | TLR7 (0.40) | TLR7PSMB5KDM4EGPR3ALDH1A1 | |
| SCHEMBL20474253 | 0.82 | PSMB5 (0.55) | PSMB5ADORA2AKDM4EALDH1A1NPSR1 | |
| SCHEMBL20474189 | 0.82 | ALDH1A1 (0.50) | PSMB5ADORA2AKDM4EALDH1A1NPSR1 | |
| SCHEMBL28671494 | 0.82 | CDK5 (0.43) | SSTR2TGFBR1MAPK14 | |
| SCHEMBL14259492 | 0.80 | PTGES (0.52) | PSMB5ALDH1A1SMN1; SMN2 | |
| SCHEMBL20474245 | 0.80 | PRNP (0.45) | PSMB5ADORA2AALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL28176611 | 0.79 | PSMB5 (0.51) | PSMB5KDM4EALDH1A1NPSR1MAPT | |
| SCHEMBL30292800 | 0.78 | ALDH1A1 (0.51) | TLR7ADORA2AKDM4EGPR3ALDH1A1 | |
| SCHEMBL28653656 | 0.78 | ALDH1A1 (0.51) | TLR7ADORA2AKDM4EGPR3ALDH1A1 | |
| SCHEMBL20799508 | 0.77 | KDM4E (0.50) | KDM4EALDH1A1MAPTSMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113683560-A | Method for preparing 3, 4-disubstituted quinoline from 1-o-aminophenyl alcohol and aromatic aldehyde | 长沙资材科技有限公司 | 2021-11-23 | — | — | CN | disclosed |
| US-11121328-B2 | Synthesis of platinum and palladium complexes as narrow-band phosphorescent emitters for full color displays | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2021-09-14 | — | — | US | disclosed |
| US-20200403167-A1 | Synthesis of Platinum and Palladium Complexes as Narrow-Band Phosphorescent Emitters for Full Color Displays | NATIONAL SCIENCE FOUNDATION | 2020-12-24 | — | — | US | disclosed |
| US-10804476-B2 | Synthesis of platinum and palladium complexes as narrow-band phosphorescent emitters for full color displays | ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2020-10-13 | — | — | US | disclosed |
| US-9698359-B2 | Synthesis of platinum and palladium complexes as narrow-band phosphorescent emitters for full color displays | ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2017-07-04 | — | — | US | disclosed |
| EP-0093521-A2 | Quinoline derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1983-11-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11121328-B2 | Synthesis of platinum and palladium complexes as narrow-band phosphorescent emitters for full color displays | DPYD, PAICS, PDCD11 | TLR7 4628/4885PSMB5 4386/4885ADORA2A 2190/4885 |
| US-20200403167-A1 | Synthesis of Platinum and Palladium Complexes as Narrow-Band Phosphorescent Emitters for Full Color Displays | DPYD, PAICS, PDCD11 | TLR7 4628/4885PSMB5 4386/4885ADORA2A 2190/4885 |
| US-10804476-B2 | Synthesis of platinum and palladium complexes as narrow-band phosphorescent emitters for full color displays | DPYD, PAICS, PDCD11 | TLR7 4628/4885PSMB5 4386/4885ADORA2A 2190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.